Idiopathic Pulmonary Fibrosis:Addressing the
current and future therapeutic advances along with the role of
Sotatercept in the management of pulmonary hypertension
Authors:
Dalia Dhia Hadi1, Mohammed Dheyaa Marsool
Marsool1*, Ali Dheyaa Marsool
Marsool1, Neel Vora2, Sajjad Ghanim
Al-Badri3, Nabeel Hamzah Kadhim
Al-Fatlawi3, Ameer Fadhil Abbas Al
Wssawi4, Abdullah Muataz Taha
Al-Ibraheem1, Khadija Ali Hamza1, ,
Priyadarshi Prajjwal5, Mohammed Abdul
Mateen6 Omniat Amir7
1Internal Medicine, University of Baghdad/Al-Kindy
College of Medicine, Baghdad, Iraq
2Internal Medicine, B. J. Medical College, Ahmedabad,
India
3Internal Medicine, University of Baghdad, College of
Medicine, Baghdad, Iraq
4Internal Medicine, University of Al-Qadisiyah College
of Medicine, Diwaniya, Iraq
5Internal Medicine, Internal Medicine, Bharati
Vidyapeeth University Medical College, Pune, India
6Inernal Medicine, Internal Medicine, Shadan Institute
of Medical Sciences teaching hospital and research center, Hyderabad,
India
7Internal Medicine, Al Manhal Academy, Khartoum, Sudan
*Correspondence: Omniat Amir. Al Manhal Academy, Khartoum, Sudan
omniatamir123@gmail.com